Drugmakers hike prices regardless of rebates, says PCMA

Posted on

Some high-priced drugs like Sovaldi, a hepatitis C drug which initially cost $84,000, involved no rebates until other competitors came to market.

from Healthcarecare Finance News Feed http://www.healthcarefinancenews.com/news/drugmakers-hike-prices-regardless-rebates-says-pcma

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s